Kaplan-Meier graphs for breast cancer incidence in the tamoxifen arm

PDF) Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trial

Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I tr

Ivana SESTAK, Associate Professor in Medical Statistics, Queen Mary, University of London, London, QMUL, Wolfson Institute of Preventive Medicine

Ivana SESTAK, Associate Professor in Medical Statistics, Queen Mary, University of London, London, QMUL, Wolfson Institute of Preventive Medicine

PDF) Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trial

Ivana SESTAK, Associate Professor in Medical Statistics, Queen Mary, University of London, London, QMUL, Wolfson Institute of Preventive Medicine

PDF) Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trial

Ivana SESTAK, Associate Professor in Medical Statistics, Queen Mary, University of London, London, QMUL, Wolfson Institute of Preventive Medicine

Ivana SESTAK, Associate Professor in Medical Statistics, Queen Mary, University of London, London, QMUL, Wolfson Institute of Preventive Medicine

PDF) Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trial

PDF) Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trial

Ivana SESTAK, Associate Professor in Medical Statistics, Queen Mary, University of London, London, QMUL, Wolfson Institute of Preventive Medicine